NARA Discovery
Article Details
← Back to Search Results
Journal Article

Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome

William P. Duggan; Manuela Salvucci; Batuhan Kisakol; Andreas U. Lindner; Ian S. Reynolds; Heiko Dussmann; Joanna Fay; Tony O’Grady; Daniel B. Longley; Fiona Ginty; Elizabeth Mc Donough; Daniel J. Slade; John P. Burke; Jochen H. M. Prehn
Journal of Molecular Medicine · Vol. 101, Issue 7 · pp. 829-841 · 2023

Abstract

There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium may be especially prevalent in mucinous CRC. The objectives of this study were to assess the association of Fusobacterium abundance with immune cell composition and prognosis in mucinous CRC. Our study included two independent colorectal cancer patient cohorts, The Cancer Genome Atlas (TCGA) cohort, and a cohort of rectal cancers from the Beaumont RCSI Cancer Centre (BRCC). Multiplexed immunofluorescence staining of a tumour microarray (TMA) from the BRCC cohort was undertaken using Cell DIVE technology. Our cohorts included 87 cases (13.3%) of mucinous and 565 cases (86.7%) of non-mucinous CRC. Mucinous CRC in the TCGA dataset was associated with an increased proportion of CD8 + lymphocytes ( p = 0.018), regulatory T-cells ( p = 0.001) and M2 macrophages ( p = 0.001). In the BRCC cohort, mucinous RC was associated with enhanced CD8 + lymphocyte ( p = 0.022), regulatory T-cell ( p = 0.047), and B-cell ( p = 0.025) counts. High Fusobacterium abundance was associated with an increased proportion of CD4 + lymphocytes ( p = 0.031) and M1 macrophages ( p = 0.006), whilst M2 macrophages ( p = 0.043) were under-represented in this cohort. Patients with increased Fusobacterium relative abundance in our mucinous CRC TCGA cohort tended to have better clinical outcomes (DSS: likelihood ratio p = 0.04, logrank p = 0.052). Fusobacterium abundance may be associated with improved outcomes in mucinous CRC, possibly due to a modulatory effect on the host immune response. Key messages • Increased Fusobacterium relative abundance was not found to be associated with microsatellite instability in mucinous CRC. • Increased Fusobacterium relative abundance was associated with an M2/M1 macrophage switch, which is especially significant in mucinous CRC, where M2 macrophages are overexpressed. • Increased Fusobacterium relative abundance was associated with a significant improvement in disease specific survival in mucinous CRC. • Our findings were validated at a protein level within our own in house mucinous and non-mucinous rectal cancer cohorts.

Bibliographic Information

JournalJournal of Molecular Medicine
PublisherSpringer
Publication Date2023-07-01
Publication Year2023
Volume101
Issue7
Pages829-841
Document TypeJournal Article
Print ISSN0946-2716
eISSN1432-1440
DOI10.1007/s00109-023-02324-5

Access Information

NARA Access Coverage1922-01-01~Current
Journal Homepagehttps://www.springer.com/journal/109
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.